P N Meissner

Author PubWeight™ 17.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anaesthesia for the porphyric patient. Anaesthesia 1993 3.12
2 The acute porphyrias. Lancet 1997 1.80
3 Purification of and kinetic studies on a cloned protoporphyrinogen oxidase from the aerobic bacterium Bacillus subtilis. Arch Biochem Biophys 1998 0.95
4 Molecular characterization of erythropoietic protoporphyria in South Africa. Br J Dermatol 2008 0.92
5 Protoporphyrinogen oxidase and porphobilinogen deaminase in variegate porphyria. Eur J Clin Invest 1986 0.89
6 Homozygous variegate porphyria: an evolving clinical syndrome. Postgrad Med J 1993 0.88
7 A systematic study of the clinical and biochemical expression of variegate porphyria in a large South African family. Br J Dermatol 2004 0.87
8 Homozygous variegate porphyria in South Africa: genotypic analysis in two cases. Mol Genet Metab 2000 0.86
9 Variegate porphyria. Semin Liver Dis 1998 0.84
10 The effect of oral activated charcoal on the course of congenital erythropoietic porphyria. Br J Dermatol 1993 0.82
11 Hepatoerythropoietic porphyria precipitated by viral hepatitis. Gut 1993 0.81
12 Identification of the first variegate porphyria mutation in an indigenous black South African and further evidence for heterogeneity in variegate porphyria. Mol Genet Metab 2001 0.81
13 Variegate porphyria in South Africa, 1688-1996--new developments in an old disease. S Afr Med J 1997 0.77
14 Porphyrinogenicity of etomidate and ketamine as continuous infusions. Screening in the DDC-primed rat model. Br J Anaesth 1985 0.77
15 Purification of human erythrocyte porphobilinogen deaminase. S Afr Med J 1991 0.77
16 Identification and characterisation of a deletion (537delAT) in the protoporphyrinogen oxidase gene in a South African variegate porphyria family. Hum Mutat 1998 0.77
17 Porphyria cutanea tarda: the etiological importance of mutations in the HFE gene and viral infection is population-dependent. Cell Mol Biol (Noisy-le-grand) 2002 0.75
18 Safety of vancomycin in acute porphyria. Br J Clin Pharmacol 1990 0.75
19 The clinical diagnosis, prevention and management of the hepatic porphyrias. Trop Gastroenterol 1997 0.75
20 Administration of oral activated charcoal in variegate porphyria results in a paradoxical clinical and biochemical deterioration. Br J Dermatol 2003 0.75
21 Prophylaxis and treatment of malaria in people with the acute porphyrias. S Afr Med J 1988 0.75
22 The expression of protoporphyrinogen oxidase in human tissues. Cell Mol Biol (Noisy-le-grand) 2009 0.75
23 Uroporphyrinogen decarboxylase and protoporphyrinogen oxidase in dual porphyria. S Afr Med J 1989 0.75
24 Carbamazepine and haem biosynthesis. Lancet 1983 0.75
25 Diagnosis of variegate porphyria at birth by demonstration of the R59W mutation. S Afr Med J 1997 0.75
26 Acute intermittent porphyria--an underdiagnosed cause of abdominal pain. S Afr Med J 1989 0.75
27 Mapping of the variegate porphyria (VP) gene: contradictory evidence for linkage between VP and microsatellite markers at chromosome 14q32. Hum Genet 1996 0.75